Fulgent Genetics (FLGT) Net Margin (2015 - 2026)

Fulgent Genetics has disclosed Net Margin across 11 years of filings, most recently posting 34.9% for Q1 2026.

• Net Margin for Q1 2026 came in at 34.9%, down 1920.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 31.09% (down 1715.0% YoY), and the FY2025 annual result was 18.75%, down 369.0% from the prior year.
• Net Margin came in at 34.9% for Q1 2026 at Fulgent Genetics, up from 5854.5% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 47.95% in Q1 2022 to a low of 5854.5% in Q4 2025.
• The 5-year median for Net Margin is 16.12% (2025), against an average of 386.02%.
• Across the five-year window, Net Margin jumped 17403 bps in 2024 and tumbled 584677 bps in 2025, its largest moves.
• Fulgent Genetics' Net Margin stood at 1.27% in 2022, then slumped by 14399 bps to 181.76% in 2023, then jumped by 96 bps to 7.73% in 2024, then slumped by 75680 bps to 5854.5% in 2025, then surged by 99 bps to 34.9% in 2026.
• The last three Net Margin figures came in at 34.9% (Q1 2026), 5854.5% (Q4 2025), and 7.86% (Q3 2025), per Business Quant data.